102 related articles for article (PubMed ID: 8764591)
1. N-linked oligosaccharides are required for cell surface expression of the norepinephrine transporter but do not influence substrate or inhibitor recognition.
Nguyen TT; Amara SG
J Neurochem; 1996 Aug; 67(2):645-55. PubMed ID: 8764591
[TBL] [Abstract][Full Text] [Related]
2. Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition.
Melikian HE; Ramamoorthy S; Tate CG; Blakely RD
Mol Pharmacol; 1996 Aug; 50(2):266-76. PubMed ID: 8700133
[TBL] [Abstract][Full Text] [Related]
3. Human norepinephrine transporter. Biosynthetic studies using a site-directed polyclonal antibody.
Melikian HE; McDonald JK; Gu H; Rudnick G; Moore KR; Blakely RD
J Biol Chem; 1994 Apr; 269(16):12290-7. PubMed ID: 8163533
[TBL] [Abstract][Full Text] [Related]
4. Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins.
Apparsundaram S; Schroeter S; Giovanetti E; Blakely RD
J Pharmacol Exp Ther; 1998 Nov; 287(2):744-51. PubMed ID: 9808705
[TBL] [Abstract][Full Text] [Related]
5. Biosynthesis, N-glycosylation, and surface trafficking of biogenic amine transporter proteins.
Ramamoorthy S; Melikian HE; Qian Y; Blakely RD
Methods Enzymol; 1998; 296():347-70. PubMed ID: 9779460
[No Abstract] [Full Text] [Related]
6. The Role of N-Glycosylation in Maintaining the Transporter Activity and Expression of Human Oligopeptide Transporter 1.
Chan T; Lu X; Shams T; Zhu L; Murray M; Zhou F
Mol Pharm; 2016 Oct; 13(10):3449-3456. PubMed ID: 27547863
[TBL] [Abstract][Full Text] [Related]
7. Molecular physiology of norepinephrine and serotonin transporters.
Blakely RD; De Felice LJ; Hartzell HC
J Exp Biol; 1994 Nov; 196():263-81. PubMed ID: 7823027
[TBL] [Abstract][Full Text] [Related]
8. Permeation and gating residues in serotonin transporter.
Chen JG; Rudnick G
Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1044-9. PubMed ID: 10655481
[TBL] [Abstract][Full Text] [Related]
9. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
Wall SC; Gu H; Rudnick G
Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
[TBL] [Abstract][Full Text] [Related]
10. Antipeptide antibodies confirm the topology of the human norepinephrine transporter.
Brüss M; Hammermann R; Brimijoin S; Bönisch H
J Biol Chem; 1995 Apr; 270(16):9197-201. PubMed ID: 7721836
[TBL] [Abstract][Full Text] [Related]
11. Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters.
Kocabas AM; Rudnick G; Kilic F
J Neurochem; 2003 Jun; 85(6):1513-20. PubMed ID: 12787070
[TBL] [Abstract][Full Text] [Related]
12. Acute regulation of norepinephrine transport: I. protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells.
Apparsundaram S; Galli A; DeFelice LJ; Hartzell HC; Blakely RD
J Pharmacol Exp Ther; 1998 Nov; 287(2):733-43. PubMed ID: 9808704
[TBL] [Abstract][Full Text] [Related]
13. Effects of serine mutations in transmembrane domain 7 of the human norepinephrine transporter on substrate binding and transport.
Danek Burgess KS; Justice JB
J Neurochem; 1999 Aug; 73(2):656-64. PubMed ID: 10428062
[TBL] [Abstract][Full Text] [Related]
14. Organization of the membrane domain of the human liver sodium/bile acid cotransporter.
Hallén S; Mareninova O; Brändén M; Sachs G
Biochemistry; 2002 Jun; 41(23):7253-66. PubMed ID: 12044156
[TBL] [Abstract][Full Text] [Related]
15. Glycosylation of a vesicular monoamine transporter: a mutation in a conserved proline residue affects the activity, glycosylation, and localization of the transporter.
Yelin R; Steiner-Mordoch S; Aroeti B; Schuldiner S
J Neurochem; 1998 Dec; 71(6):2518-27. PubMed ID: 9832151
[TBL] [Abstract][Full Text] [Related]
16. Delineation of an endogenous zinc-binding site in the human dopamine transporter.
Norregaard L; Frederiksen D; Nielsen EO; Gether U
EMBO J; 1998 Aug; 17(15):4266-73. PubMed ID: 9687495
[TBL] [Abstract][Full Text] [Related]
17. Role of glycosylation in the organic anion transporter OAT1.
Tanaka K; Xu W; Zhou F; You G
J Biol Chem; 2004 Apr; 279(15):14961-6. PubMed ID: 14749323
[TBL] [Abstract][Full Text] [Related]
18. Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter.
Barker EL; Blakely RD
Mol Pharmacol; 1996 Oct; 50(4):957-65. PubMed ID: 8863842
[TBL] [Abstract][Full Text] [Related]
19. Identification of the histidyl residue obligatory for the catalytic activity of the human H+/peptide cotransporters PEPT1 and PEPT2.
Fei YJ; Liu W; Prasad PD; Kekuda R; Oblak TG; Ganapathy V; Leibach FH
Biochemistry; 1997 Jan; 36(2):452-60. PubMed ID: 9003198
[TBL] [Abstract][Full Text] [Related]
20. The NH(2)-terminus of norepinephrine transporter contains a basolateral localization signal for epithelial cells.
Gu HH; Wu X; Giros B; Caron MG; Caplan MJ; Rudnick G
Mol Biol Cell; 2001 Dec; 12(12):3797-807. PubMed ID: 11739781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
